Skip to main content

Insulin makers accused of price-fixing in a class-action lawsuit

By Business Insider  
   January 31, 2017

A lawsuit filed Monday alleges that the three companies that make insulin have been part of an "organized scheme to drive up prices at the expense of patients who need insulin drugs to live."


Full story

Get the latest on healthcare leadership in your inbox.